» Articles » PMID: 38969944

Sustained Delivery of Celecoxib from Nanoparticles Embedded in Hydrogel Injected into the Biopsy Cavity to Prevent Biopsy-induced Breast Cancer Metastasis

Abstract

Purpose: We have previously reported that protracted Cyclooxygenase-2 (COX-2) activity in bone marrow-derived cells (BMDCs) infiltrating into biopsy wounds adjacent to the biopsy cavity of breast tumors in mice promotes M2-shift of macrophages and pro-metastatic changes in cancer cells, effects which were suppressed by oral administration of COX-2 inhibitors. Thus, local control of COX-2 activity in the biopsy wound may mitigate biopsy-induced pro-metastatic changes.

Methods: A combinatorial delivery system-thermosensitive biodegradable poly(lactic acid) hydrogel (PLA-gel) incorporating celecoxib-encapsulated poly(lactic-co-glycolic acid) nanoparticles (Cx-NP/PLA-gel)-was injected into the biopsy cavity of Py230 murine breast tumors to achieve local control of COX-2 activity in the wound stroma.

Results: A single intra-biopsy cavity injection of PLA-gel loaded with rhodamine-encapsulated nanoparticles (NPs) showed sustained local delivery of rhodamine preferentially to infiltrating BMDCs with minimal to no rhodamine uptake by the reticuloendothelial organs in mice. Moreover, significant reductions in M2-like macrophage density, cancer cell epithelial-to-mesenchymal transition, and blood vessel density were observed in response to a single intra-biopsy cavity injection of Cx-NP/PLA-gel compared to PLA-gel loaded with NPs containing no payload. Accordingly, intra-biopsy cavity injection of Cx-NP/PLA-gel led to significantly fewer metastatic cells in the lungs than control-treated mice.

Conclusion: This study provides evidence for the feasibility of sustained, local delivery of payload preferential to BMDCs in the wound stroma adjacent to the biopsy cavity using a combinatorial delivery system to reduce localized inflammation and effectively mitigate breast cancer cell dissemination.

References
1.
Maeda H, Bharate G, Daruwalla J . Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2008; 71(3):409-19. DOI: 10.1016/j.ejpb.2008.11.010. View

2.
Maridas D, Rendina-Ruedy E, Le P, Rosen C . Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice. J Vis Exp. 2018; (131). PMC: 5908449. DOI: 10.3791/56750. View

3.
Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim J, Sun Y . Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. Cell Rep Med. 2023; 4(12):101330. PMC: 10772461. DOI: 10.1016/j.xcrm.2023.101330. View

4.
Wicki A, Witzigmann D, Balasubramanian V, Huwyler J . Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2014; 200:138-57. DOI: 10.1016/j.jconrel.2014.12.030. View

5.
Eriksson L, Bergh J, Humphreys K, Warnberg F, Tornberg S, Czene K . Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study. Int J Cancer. 2018; 143(5):1093-1104. DOI: 10.1002/ijc.31411. View